Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.2418
Delayed Data
As of 12:04pm ET
 +0.0023 / +0.96%
Today’s Change
0.17
Today|||52-Week Range
0.40
+6.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Operating ActivitiesNet Income / Starting Line-15.1M1.5M-96.6M28.9M
 
 
 
 
 
Depreciation484.2K423.3K453.7K581.9K
 
 
 
 
 
Total Other Cash Flow13.8M-2.7M91.9M-44.5M
 
 
 
 
 
Funds From Operations-765.9K-793.9K-4.2M-14.9M
 
 
 
 
 
Funds From/For Other Operating Expenses-371.8K1.1M-32.0K163.1K
 
 
 
 
 
Net Cash Flow - Operating Activities-394.1K-1.9M-4.2M-15.1M
 
 
 
 
 
 
InvestingDecrease In Investments--0.000.005.0M
 
 
Capital Expenditures-623.3K-153.0K-502.3K-2.0M
 
 
 
 
 
Other Investing - Uses0.00-1.000.000.00
 
 
Other Investing - Sources10.8K12.8K2.8K-123.9K
 
 
 
 
 
Net Cash Flow Investing-657.8K-191.8K-557.7K2.9M
 
 
 
 
 
 
FinancingShort Term Borrowings-13.4K593.7K527.2K-164.7K
 
 
 
 
 
Long Term Borrowings--0.000.000.00--
Long Term Debt Reduction--0.000.00-1.1M
 
 
Net Proceeds Stock Sale-92.2K1.0M10.9M14.0M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00240.1K1.000.00
 
 
 
Other Uses - Financing0.000.0048.0K0.00
 
 
Net Cash Flow - Financing-105.6K1.8M11.3M12.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.000.000.00--
 
Net Change In Cash-1.2M-299.4K6.6M522.4K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account